Me, a pioneer in genetic testing, struggles to maintain its early success. As quickly as it soared, its market value ...

( NewsNation) — Genetic testing company 23andMe has faced a series of struggles this year, culminating in end-of-year mass ...

o. 23andMe is considered a direct-to-consumer genetic testing company, and transactions with the company are considered ...

23andMe, the struggling ancestry tracing company, continues to spiral, raising questions about its business prospects and what could happen to its sensitive customer genetic testing data. CEO Anne ...

Meanwhile, Hims & Hers tackles the GLP-1 shortage with a new app; Eli Lilly releases data on tirzepatide efficacy; 23andMe faces privacy concerns; and more.

Me just dropped some major news in a tough year for the genetic testing company. After months of financial challenges, data ...

The financial struggles of genetic testing and ancestry company 23andMe are raising questions about the security of customers ...

Concerns about 23andMe's business prospects is raising questions about the genetic testing company's customer data.

The genetic testing firm will also close its therapeutics arm. CEO Anne Wojcicki said the cuts are necessary to “focus on the ...

On Tuesday, direct-to-consumer genetic testing firm 23andMe announced it would be shuttering its much-hyped drug development ...

Home genetics company 23andMe continues to struggle as demand for casual gene tracing declines. On Monday, the company announced that it has decided on a restructuring ...